Concord Investment Counsel’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$194K Sell
1,318
-75
-5% -$12.2K 0.07% 36
2025
Q4
$272K Sell
1,393
-450
-24% -$107K 0.09% 33
2025
Q3
$518K Buy
+1,843
New +$469K 0.16% 32
2024
Q1
$478K Buy
+3,805
New +$436K 0.17% 39

Other funds holding ORCL

Concord Investment Counsel's ORCL Position: Q1 2026 in Review

Concord Investment Counsel reduced its Oracle (ORCL) stake by 5.4% in Q1 2026, selling an estimated $12.2K and leaving 1,318 shares worth $194K. The position accounts for 0.07% of the portfolio, ranked #36.

Concord Investment Counsel first reported a position in ORCL in Q1 2024 and has held it in 4 quarters since. The position peaked at $518K in Q3 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Concord Investment Counsel held 1,318 shares of Oracle worth $194K as of Q1 2026.
  • Concord Investment Counsel sold 75 Oracle shares in Q1 2026, an estimated $12.2K.
  • Oracle made up 0.07% of Concord Investment Counsel's portfolio in Q1 2026, its #36 holding.
  • Concord Investment Counsel first reported a position in Oracle in Q1 2024 and has held it in 4 quarters since.
  • Concord Investment Counsel's Oracle position peaked at $518K in Q3 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Concord Investment Counsel's 13F filing for Q1 2026, filed 13 May 2026.